| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 22, 2024 | RXST Rxsight, Inc. | Weinberg Eric57 | Chief Commercial Officer | Sell | 10,000 | $48.00 | $480,006.00 | -3.1% | +10.4% | -34.7% | |
| Jan 22, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,546 | $1.22 | $6,766.12 | - | -12.3% | -33.7% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 1,232 | $16.76 | $20,648.32 | -1.1% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | De Greef Roderick74 | President And CEO | Sell | 2,642 | $16.76 | $44,279.92 | -0.6% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 862 | $16.76 | $14,447.12 | -2.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 1,198 | $16.76 | $20,078.48 | -1.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 2,419 | $16.76 | $40,542.44 | -3.6% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 1,450 | $16.76 | $24,302.00 | -0.5% | -7.6% | +52.2% | |
| Jan 19, 2024 | BLFS Biolife Solutions Inc | Phillips Geraint | SVP, Global Operations | Sell | 1,776 | $16.76 | $29,765.76 | -3.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | VTAK Catheter Precision, Inc. | Jenkins David A | Executive Chairman And CEO | Buy | 16,940 | $0.42 | $7,086.00 | +2.8% | +13.2% | -89.2% | |
| Jan 18, 2024 | GKOS Glaukos Corp | Thurman Alex R.50 | SVP &Chief Financial Officer | Sell | 583 | $90.54 | $52,783.86 | -0.5% | +6.7% | +72.2% | |
| Jan 18, 2024 | RXST Rxsight, Inc. | Maniar Shweta62 | Director | Sell | 6,399 | $45.72 | $292,555.46 | -19.1% | +14.0% | -34.4% | |
| Jan 18, 2024 | LUNG Pulmonx Corp | French Glendon E. III84 | President And CEO | Sell | 10,000 | $12.77 | $127,700.00 | -0.9% | -42.1% | -51.2% | |
| Jan 18, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 4,495 | $1.20 | $5,381.06 | - | -13.7% | -34.6% | |
| Jan 17, 2024 | SGHT Sight Sciences, Inc. | Park Sam Boong67 | Chief Operating Officer | Sell | 5,443 | $5.16 | $28,107.65 | -5.1% | -0.6% | -46.0% | |
| Jan 17, 2024 | SGHT Sight Sciences, Inc. | Badawi David59 | Chief Technology Officer | Sell | 3,414 | $5.16 | $17,629.90 | -0.2% | -0.6% | -46.0% | |
| Jan 17, 2024 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 15,917 | $5.16 | $82,195.39 | -0.3% | -0.6% | -46.0% | |
| Jan 17, 2024 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 4,538 | $5.16 | $23,434.23 | -30.5% | -0.6% | -46.0% | |
| Jan 16, 2024 | DXCM Dexcom Inc | Altman Steven R60 | Director | Sell | 1,568 | $122.86 | $192,652.00 | -1.4% | +8.1% | -35.4% | |
| Jan 16, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 10,000 | $80.41 | $804,087.78 | -25.7% | +15.8% | -23.8% | |
| Jan 16, 2024 | VTAK Catheter Precision, Inc. | Jenkins David A | Executive Chairman And CEO | Buy | 16,263 | $0.39 | $6,323.12 | +2.9% | +18.1% | -88.6% | |
| Jan 16, 2024 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 2,500 | $15.00 | $37,500.00 | -0.4% | -13.0% | -24.6% | |
| Jan 16, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 4,890 | $89.17 | $436,041.30 | -3.9% | +8.5% | +67.8% | |
| Jan 16, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources | Sell | 2,902 | $123.63 | $358,788.19 | -3.5% | +8.1% | -35.4% | |
| Jan 16, 2024 | OM Outset Medical, Inc. | Porter Stacey L.89 | Chief People Officer | Sell | 768 | $4.29 | $3,294.72 | -1.2% | -50.7% | -81.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.